Cowen Prime Advisors’s Eli Lilly LLY Stock Holding History

Cowen Prime Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$7.5K	Hold	16	–	–	﹤0.01%	177
2023 Q1	$6K	Buy	+16	New	+$5.4K	﹤0.01%	182
2016 Q4	–	Sell	-6	Closed	–	–	213
2016 Q3	$0	Buy	6 +1	+20%	+$80	﹤0.01%	255
2016 Q2	$0	Hold	5	–	–	﹤0.01%	236
2016 Q1	$0	Hold	5	–	–	﹤0.01%	243
2015 Q4	$0	Hold	5	–	–	﹤0.01%	244
2015 Q3	$0	Sell	5 -37	-88%	-$3.12K	﹤0.01%	262
2015 Q2	$4K	Sell	42 -1,895	-98%	-$144K	﹤0.01%	228
2015 Q1	$141K	Buy	1,937 +14	+0.7%	+$997	0.06%	134
2014 Q4	$133K	Buy	1,923 +12	+0.6%	+$810	0.05%	137
2014 Q3	$124K	Sell	1,911 -107	-5%	-$6.77K	0.05%	137
2014 Q2	$125K	Buy	2,018 +2	+0.1%	+$119	0.05%	123
2014 Q1	$119K	Buy	2,016 +16	+0.8%	+$893	0.05%	128
2013 Q4	$102K	Sell	2,000 -21	-1%	-$1.05K	0.04%	142
2013 Q3	$102K	Buy	2,021 +398	+25%	+$20.8K	0.04%	152
2013 Q2	$80K	Buy	+1,623	New	+$88.3K	0.03%	156

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Cowen Prime Advisors's LLY Position: Q2 2023 in Review

Cowen Prime Advisors held its Eli Lilly (LLY) position steady in Q2 2023 at 16 shares worth $7.5K. The position accounts for ﹤0.01% of the portfolio, ranked #177.

Cowen Prime Advisors first reported a position in LLY in Q2 2013 and has held it in 16 quarters since. The position peaked at $141K in Q1 2015. 2,815 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

Cowen Prime Advisors held 16 shares of Eli Lilly worth $7.5K as of Q2 2023.
Cowen Prime Advisors left its Eli Lilly share count unchanged in Q2 2023.
Eli Lilly made up ﹤0.01% of Cowen Prime Advisors's portfolio in Q2 2023, its #177 holding.
Cowen Prime Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 16 quarters since.
Cowen Prime Advisors's Eli Lilly position peaked at $141K in Q1 2015.
2,815 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.